Veronica Sanchez-Gonzalez

Veronica Sanchez-Gonzalez

Waltham, Massachusetts, United States
252 followers 249 connections

About

14+ years of combined experience in academia and industry. Skilled in assay developement,…

Activity

Experience

  • Repertoire Immune Medicines Graphic
  • -

    Boston, Massachusetts, United States

  • -

    Brea, California, United States

  • -

    Montreal, Canada Area

  • -

    London, Canada Area

  • -

    Toronto, Canada Area

  • -

    London, Canada Area

  • -

    San Juan Puerto Rico (USA)

Education

  •  Graphic

    -

    -

    • Assisted in developing DNA molecules that target specific proteins as an alternative
    method to antibody-based protein detection
    • Characterized a novel protein through mass spectrometry and cell based assays
    • Performed cell-based assay to investigate the potential of non-coding RNAs to arrest blood
    vessel development in cancer
    • Established in-house protocols to isolate non-coding RNAs and protein binding partners
    as a method to identify pathway regulation and possible…

    • Assisted in developing DNA molecules that target specific proteins as an alternative
    method to antibody-based protein detection
    • Characterized a novel protein through mass spectrometry and cell based assays
    • Performed cell-based assay to investigate the potential of non-coding RNAs to arrest blood
    vessel development in cancer
    • Established in-house protocols to isolate non-coding RNAs and protein binding partners
    as a method to identify pathway regulation and possible clinical outcome.
    • Responsible for the bioinfomatics analysis of several sequencing projects
    • Developed several knockout cell lines using CRISPR/Cas9 technology
    • Managed several projects and trained new students in laboratory techniques and bioinformatics.
    • Involved in the development of nanoparticles delivery of non-coding RNAs to tissues in-vivo
    • Investigated, in collaboration, the mechanism of action of a new compound inducing
    angiogenesis in-vivo

  • -

    -


    • Isolated pre- and post-implantation mouse embryos and identified different cell populations contributing to the cardiovascular development
    • Assisted engineers in the installation of a confocal microscope (swept field) capable of supporting tissue culture
    • Generated mouse-lines carrying several mutations, reporter genes and overexpressed genes
    • Improved imaging techniques previously developed by Dr. Yamanaka, and trained personnel
    • Established mouse embryonic stem cells…


    • Isolated pre- and post-implantation mouse embryos and identified different cell populations contributing to the cardiovascular development
    • Assisted engineers in the installation of a confocal microscope (swept field) capable of supporting tissue culture
    • Generated mouse-lines carrying several mutations, reporter genes and overexpressed genes
    • Improved imaging techniques previously developed by Dr. Yamanaka, and trained personnel
    • Established mouse embryonic stem cells from blastocysts
    • In charge of training new users in optical projection tomography microscopes and confocal microscopes

Volunteer Experience

  • Volunteer

    Stoneybrook Animal Hospital

    - 1 year

    Animal Welfare

Publications

  • NOX2, NOX4, and mitochondrial-derived reactive oxygen species contribute to angiopoietin-1 signaling and angiogenic responses in endothelial cells

    Vascular pharmacology

    Abstract- Angiopoietin-1 (Ang-1) is a ligand of Tie-2 receptors that promotes survival, migration, and differentiation of endothelial cells. Several studies have linked reactive oxygen species (ROS) to Ang-1 signaling and distinct angiogenic responses, but the molecular sources of these ROS have never been clearly identified. In this study, we have identified source-specific contributions of ROS to Ang-1/Tie 2 signaling and angiogenic responses in human umbilical vein endothelial cells…

    Abstract- Angiopoietin-1 (Ang-1) is a ligand of Tie-2 receptors that promotes survival, migration, and differentiation of endothelial cells. Several studies have linked reactive oxygen species (ROS) to Ang-1 signaling and distinct angiogenic responses, but the molecular sources of these ROS have never been clearly identified. In this study, we have identified source-specific contributions of ROS to Ang-1/Tie 2 signaling and angiogenic responses in human umbilical vein endothelial cells (HUVECs), specifically the differential contributions of mitochondrial ROS (mtROS) and ROS from two isoforms of NADPH oxidase (NOX2, NOX4). We demonstrate that: 1) Ang-1 induces significant increases in mtROS production under normal conditions but does not when cells are pre-incubated with mitochondrial antioxidants; 2) Ang-1 induces rapid Tie-2-dependent increases in cytosolic ROS production but does not when NOX2 and NOX4 are knocked down; 3) Ang-1 induces simultaneous increases in phosphorylation of AKT, ERK1/2, p38, and SAPK/JNK proteins within a few minutes of exposure, but this response is strongly and selectively attenuated when NOX2 and NOX4 are knocked down or cells are pre-treated with mitochondrial antioxidants; 4) Ang-1 exerts a strong effect on HUVEC survival in serum-deprived medium and enhances cell migration and capillary tube formation, but the survival response is inhibited by NOX2 knockdown and the migration and tube formation responses are entirely absent with NOX4 knockdown or pre-treatment with mitochondrial antioxidants. We conclude that Ang-1 triggers NOX2, NOX4, and the mitochondria to release ROS and that ROS derived from these sources play distinct roles in the regulation of the Ang-1/Tie 2 signaling pathway and pro-angiogenic responses.

    Other authors
  • Fibulin-5 Regulates Angiopoietin-1/Tie-2 Receptor Signaling in Endothelial Cells

    Plos One

    Abstract-Fibulin-5 is an extracellular matrix glycoprotein that plays critical roles in vasculogenesis and embryonic development. Deletion of Fibulin-5 in mice results in enhanced skin vascularization and upregulation of the angiogenesis factor angiopoietin-1 (Ang-1), suggesting that Fibulin-5 functions as an angiogenesis inhibitor. In this study, we investigate the inhibitory effects of Fibulin-5 on Ang-1/TIE-2 receptor pathway signaling and cell survival in human endothelial…

    Abstract-Fibulin-5 is an extracellular matrix glycoprotein that plays critical roles in vasculogenesis and embryonic development. Deletion of Fibulin-5 in mice results in enhanced skin vascularization and upregulation of the angiogenesis factor angiopoietin-1 (Ang-1), suggesting that Fibulin-5 functions as an angiogenesis inhibitor. In this study, we investigate the inhibitory effects of Fibulin-5 on Ang-1/TIE-2 receptor pathway signaling and cell survival in human endothelial cells.
    METHODOLOGY/PRINCIPAL FINDINGS:
    Recombinant wild-type and RGE-mutant Fibulin-5 proteins were generated through stable transfection of HEK293 and CHO cells, respectively. In vitro solid phase binding assays using pure proteins revealed that wild-type Fibulin-5 does not bind to Ang-1 or TIE-2 proteins but strongly binds to heparin. Binding assays using human umbilical vein endothelial cells (HUVECs) indicated that wild-type Fibulin-5 strongly binds to cells but RGE-mutant Fibulin-5, which is incapable of binding to integrins, does not. Pre-incubation of HUVECs for 1 hr with Fibulin-5 significantly increased caspase 3/7 activity, ERK1/2 phosphorylation, and expressions of the transcription factor early growth response 1 (EGR1) and the dual-specificity phosphatase 5 (DUSP5). Fibulin-5 also strongly attenuated Ang-1-induced TIE-2 and AKT phosphorylation, decreased Ang-1-induced expressions of the transcription factors Inhibitor of DNA Binding 1 (ID1) and Kruppel-like Factor 2 (KLF2), and reversed the inhibitory effect of Ang-1 on serum deprivation-induced cytotoxicity and caspase 3/7 activity.
    CONCLUSION/SIGNIFICANCE:
    We conclude that Fibulin-5 strongly binds to the endothelial cell surface through heparin-sulfate proteoglycans and possibly integrins and that it exerts strong anti-angiogenic effects by reducing endothelial cell viability and interfering with the signaling pathways of the Ang-1/TIE-2 receptor axis.

    Other authors
    • H. Ismail
    • W. Chan
    • D. Mayaki
    • K. Tiedemann
    • E.C. Davis
    • S. Hussain
    See publication
  • Angiopoietin-1 inhibits toll-like receptor 4 signalling in cultured endothelial cells: role of miR-146b-5p

    Cardiovascular Research

    Abstract
    AIMS:
    Bacterial lipopolysaccharides (LPS) induce innate immune inflammatory responses in endothelial cells by activating toll-like receptor 4 (TLR4) signalling. Here, we investigate the effects of angiopoietin-1 (Ang-1) on LPS-induced TLR4 signalling and the role of the miR-146 family of micro RNAs in the effects of Ang-1 on TRL4 signalling.
    METHODS AND RESULTS:
    Leucocyte adhesion to human umbilical vein endothelial cells (HUVECs) was detected using fluorescence microscopy.…

    Abstract
    AIMS:
    Bacterial lipopolysaccharides (LPS) induce innate immune inflammatory responses in endothelial cells by activating toll-like receptor 4 (TLR4) signalling. Here, we investigate the effects of angiopoietin-1 (Ang-1) on LPS-induced TLR4 signalling and the role of the miR-146 family of micro RNAs in the effects of Ang-1 on TRL4 signalling.
    METHODS AND RESULTS:
    Leucocyte adhesion to human umbilical vein endothelial cells (HUVECs) was detected using fluorescence microscopy. Adhesion molecule, pro-inflammatory cytokine, miR-146a, and miR-146b-5p expressions in HUVECs were quantified using real-time PCR. TLR4 signalling protein levels were measured using immunoblotting. Exposure of HUVECs to LPS for 4-6 h induces robust inflammatory responses, including enhanced leucocyte adhesion, up-regulation of adhesion molecule expression (VCAM1, ICAM1, E-SELECTIN), enhanced cytokine production (TNFα, IL1β, IL6, and IL8), and increased NFκB luciferase reporter activity. Addition of Ang-1 to the culture medium for 24 h prior to LPS exposure significantly attenuates these responses. Prolonged Ang-1 exposure significantly decreases IRAK1 and TRAF6 protein levels but has no effect on TLR4, MYD88, IRAK4, or TAK1 expressions. Ang-1 triggers significant up-regulation of miR-146b-5p levels but has no effect on miR-146a or miR-146b-3p expressions. Transfection of HUVECs with a miR-146b-5p mimic significantly attenuates LPS-induced inflammatory responses and IRAK1 and TRAF6 expressions. In HUVECs transfected with a miR-146b-5p inhibitor, Ang-1 has no effect on LPS-induced inflammatory responses or IRAK1 and TRAF6 expressions.
    CONCLUSION:
    Ang-1 disrupts TLR4 signalling, resulting in inhibition of LPS-induced inflammatory responses in endothelial cells. This inhibition occurs through selective targeting of IRAK1 and TRAF6 proteins by miR-146b-5p.

    Other authors
    See publication
  • Proof-of-Concept Randomized Controlled Study of Cognition Effects of the Proprietary Extract Sceletium tortuosum (Zembrin) Targeting Phosphodiesterase-4 in Cognitively Healthy Subjects: Implications for Alzheimer's Dementia.

    Evidence-Based Complementary and Alternative Medicine

    Abstract-Introduction. Converging evidence suggests that PDE-4 (phosphodiesterase subtype 4) plays a crucial role in regulating cognition via the PDE-4-cAMP cascade signaling involving phosphorylated cAMP response element binding protein (CREB). Objective. The primary endpoint was to examine the neurocognitive effects of extract Sceletium tortuosum (Zembrin) and to assess the safety and tolerability of Zembrin in cognitively healthy control subjects. Method. We chose the randomized double-blind…

    Abstract-Introduction. Converging evidence suggests that PDE-4 (phosphodiesterase subtype 4) plays a crucial role in regulating cognition via the PDE-4-cAMP cascade signaling involving phosphorylated cAMP response element binding protein (CREB). Objective. The primary endpoint was to examine the neurocognitive effects of extract Sceletium tortuosum (Zembrin) and to assess the safety and tolerability of Zembrin in cognitively healthy control subjects. Method. We chose the randomized double-blind placebo-controlled cross-over design in our study. We randomized normal healthy subjects (total n = 21) to receive either 25 mg capsule Zembrin or placebo capsule once daily for 3 weeks, in a randomized placebo-controlled 3-week cross-over design. We administered battery of neuropsychological tests: CNS Vital Signs and Hamilton depression rating scale (HAM-D) at baseline and regular intervals and monitored side effects with treatment emergent adverse events scale. Results. 21 subjects (mean age: 54.6 years ± 6.0 yrs; male/female ratio: 9/12) entered the study. Zembrin at 25 mg daily dosage significantly improved cognitive set flexibility (P < 0.032) and executive function (P < 0.022), compared with the placebo group. Positive changes in mood and sleep were found. Zembrin was well tolerated. Conclusion. The promising cognitive enhancing effects of Zembrin likely implicate the PDE-4-cAMP-CREB cascade, a novel drug target in the potential treatment of early Alzheimer's dementia. This trial is registered with ClinicalTrials.gov NCT01805518

    Other authors
    • S. Chiu
    • N. Gericke
    • M. Woodbury-Farina
    • V. Badmaev
    • J. Antongiorgi
    • Y. Bureau
    • Z. Cernovsky
    • M. Williams
    See publication
  • The role of nutrient-based epigenetic changes in buffering against stress, aging, and Alzheimer's disease.

    Psychiatric Clinics of North America

    Converging evidence identifies stress-related disorders as putative risk factors for Alzheimer Disease (AD). This article reviews evidence on the complex interplay of stress, aging, and genes-epigenetics interactions. The recent classification of AD into preclinical, mild cognitive impairment, and AD offers a window for intervention to prevent, delay, or modify the course of AD. Evidence in support of the cognitive effects of epigenetics-diet, and nutraceuticals is reviewed. A proactive…

    Converging evidence identifies stress-related disorders as putative risk factors for Alzheimer Disease (AD). This article reviews evidence on the complex interplay of stress, aging, and genes-epigenetics interactions. The recent classification of AD into preclinical, mild cognitive impairment, and AD offers a window for intervention to prevent, delay, or modify the course of AD. Evidence in support of the cognitive effects of epigenetics-diet, and nutraceuticals is reviewed. A proactive epigenetics diet and nutraceuticals program holds promise as potential buffer against the negative impact of aging and stress responses on cognition, and can optimize vascular, metabolic, and brain health in the community.

    Other authors
    • S. Chiu
    • M. Woodbury-Farina
    • M. Shad
    • M. Husni
    • J. Copen
    • Y. Bureau
    • Z. Cernovsky
    • J.J. Hou
    • R. Campbell
    See publication

Languages

  • Spanish

    Native or bilingual proficiency

  • English

    Native or bilingual proficiency

  • French

    Professional working proficiency

View Veronica’s full profile

  • See who you know in common
  • Get introduced
  • Contact Veronica directly
Join to view full profile

People also viewed

Explore collaborative articles

We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.

Explore More

Others named Veronica Sanchez-Gonzalez

Add new skills with these courses